BURLINGAME, Calif., May 6 /PRNewswire/ -- Epitomics, Inc. announced today that its Hangzhou subsidiary has received ISO 9001-2000 certification for the development and production of its novel line of rabbit monoclonal antibodies. "This certification demonstrates our commitment to establishing a standard for quality management and ultimately the finest quality antibodies available to meet our customers' needs." said Dr. Guo-Liang Yu, President and CEO of Epitomics, Inc.
"ISO certification is a very important milestone for the company and an independent validation of our quality system to ensure high quality products for our customers" said Dr. Y. Peter Li, Senior VP of Product Development for Epitomics. The ISO standard provides common worldwide criteria for effective quality management and covers twenty areas including design, document control, inspection, testing, servicing and training. ISO 9001 certification is received upon successful completion of an accredited third party audit and provides independent validation that Epitomics quality management system meets the high standard of quality set forth by the International Organization for Standardization (ISO).
Epitomics Hangzhou facility is involved with the design and manufacture of Epitomics' proprietary RabMAbs(TM) (Rabbit Monoclonal Antibodies) for research, diagnostic and therapeutic applications. With ISO certification, Epitomics will continue updating and refining its' quality management processes and procedures to provide customers with the best quality antibodies available.
About Epitomics
Epitomics, Inc., an emerging biotechnology company, is dedicated to developing its breakthrough rabbit monoclonal antibody technology for research, diagnostic and therapeutic applications. The Company utilizes a unique and proprietary RabMAb(TM) (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity and bioactivity in a wide variety of biological assays. The Company is headquartered in Burlingame, California, and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. More information about Epitomics can be found at http://www.epitomics.com
CONTACT: Abe Couse of Epitomics, Inc., 1-877-772-2622,
abe.couse@epitomics.com
Web site: http://www.epitomics.com/
